FDA Death Toll Will Drop Slightlyby Brad Warbiany
The Food and Drug Administration yesterday unveiled a proposal designed to give thousands of seriously ill patients easier access to experimental treatments.
The proposal would clarify how patients can become eligible to get drugs that are showing promise but have not been fully tested to determine their safety and effectiveness, officials said. The plan would make it easier for researchers, drug companies and research institutes to determine how much they could charge patients getting drugs early, they said.
“From a political standpoint, it reflects the current mind-set of the agency, which is: ‘Whatever we do to ensure that products that are approved have the most rigorous safety data possible, we are not going to deny people who have no therapeutic options access to experimental drugs,” said Kenneth Kaiten of Tufts University.
So basically, they’re saying that if you’ve already got a death sentence and you’re willing to try an unapproved miracle drug for a final appeal, they just might allow you to. Because it’s their job to make a decision for you as to exactly how hard you can fight for your life.
It’s not exactly privatization of the FDA, but at least it’s a good step to not be keeping people from having access to drugs that could potentially provide major improvement to their lives, and is at the very least a pro-liberty maneuver.